In-room imaging and MR planning

STOMP trial results

- 62 patients with oligorecurrence (≤ 3 M+) on Choline-PET/CT after primary Pca treatment with curative intent.

- Surveillance vs. MDT (surgery or SBRT).

- Primary endpoint = ADT-free survival.

- Median fup 3 years: 21 vs. 13 m ADT- free survival (p = 0,11).

Ost P. et al. JCO 2017.

61